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TOO MUCH OF A GOOD THING? PUBLIC ACCESS TO
MEDICAL RESEARCH IN WASHINGTON AFTER
PAWS V. U.W.
Russell K. Yoshinaka
Abstract- In Progressive Animal Welfare Society v. University of Washington, the
Washington State Supreme Court held that Washington's Public Disclosure Act mandated
public access to unfunded medical research grant proposals submitted by researchers to public
institutions within the state. This holding conflicts with federal policy and the current national
standard of maintaining full confidentiality of research grant proposals until after research
actually is funded. This Note examines the harmful impact that this decision will have on
medical research conducted in Washington and the implications for Washington's
biotechnology industry. It recommends that both the Washington legislature and Congress act
to ensure that unfunded medical research proposals are exempt in their entirety from state and
federal public disclosure laws.

Progressive Animal Welfare Society (PAWS) is an animal fights
activist organization opposed to the use of animals in all medical
research. On January 9, 1991, PAWS requested from the University of
Washington (U.W.) a copy of an unfunded research grant proposal1
submitted jointly by researchers from the University of Washington and
the Johns Hopkins University. After U.W. officials denied the request,
PAWS filed suit to compel disclosure of the proposal pursuant to
Washington's Public Disclosure Act.' Almost four years after PAWS's
initial request, the Washington Supreme Court affirmed the trial court's
holding that the entire unfunded medical research grant proposal was not
exempt from disclosure.3 The court ordered U.W. to give PAWS access
1. A medical research grant proposal contains, among other things, a detailed description of the
research plan including its specific aims, background and significance, and experimental designs and
methods. See, e.g., Application for Public Health Service Grant, Form PHS 398, U.S. Department of
Health and Human Services, 19-22 [hereinafter PHS Grant Application].
2. Wash. Rev. Code § 42.17.340 (1994).
3. The Washington Supreme Court granted direct review of the appeal. Progressive Animal
Welfare Society v. University of Washington, 125 Wash. 2d 243, 884 P.2d 592 (1994). As this book
went to press, this case was on remand at the trial court level for a ruling on PAWS's motion for
statutory penalties pursuant to Wash. Rev. Code § 42.17.340(4). See infra note 31 and
accompanying text. PAWS contends that U.W. failed to disclose all of the documents ordered by the
court to be released and acted in bad faith in denying the original disclosure request. PAWS's
Memorandum re: Attorney Fees and Statutory Penalties, Progressive Animal Welfare Society v.
University of Washington (No. 91-2-07148-9). According to U.W., however, Dr. Gene Sackett acted
as a subcontractor in the collaborative research with Dr. Linda Cork and as such was given only the
portions needed for his own contribution as a subcontractor. Thus, according to U.W. it never
possessed the entire proposal and PAWS was given all of the documents within the possession of
U.W. University of Washington's Memorandum Regarding Statutory Penalties and Disclosure of
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to the proposal with the exception of certain material redacted by the trial
court. Because the redacted material might allow an educated reader to
deduce "valuable formulae, designs, drawings, and research data," it was
exempt from disclosure.4
State and federal public disclosure laws attempt to maintain a delicate
balance between the public's right to know and the need for the fair and
efficient administration of government. Of the many governmental
functions within the scope of the public disclosure laws, perhaps none
deserves greater care in applying these laws than the government's
sponsorship of medical research. Washington's liberal interpretation of
its public disclosure law deviates from the current national standard of
maintaining the confidentiality of research proposals until after the
research is funded by a governmental agency.' This results in a counterproductive policy toward medical research conducted in Washington,
places Washington research institutions at a competitive disadvantage,
and may threaten the development of valuable and potentially life-saving
inventions.
This Note begins with background discussion of Washington's Public
Disclosure Act,6 the federal Freedom of Information Act,7 and the current
national standards on disclosure of unfunded research proposals. Part II
discusses the funding process for medical research! Part I sets forth the
facts and holding of PAWS v. U. W.9 Part IV then analyzes this holding,
Documents at 8, PAWS v. U.W. (No. 91-2-07148-9). The issue on remand and its disposition has no
bearing on the issues discussed in this Note.
4. Wash. Rev. Code § 42.17.310(l)(h) (1994).
5. Only two reported federal cases have dealt with disclosure requests involving medical research
proposals. Washington Research Project, Inc. v. Department of Health, Education and Welfare, 504
F.2d 238 (D.C. Cir. 1974), cert. denied, 421 U.S. 963 (1975), involved disclosure of a funded
proposal. Kurzon v. Department of Health & Human Services, 649 F.2d 65 (1st Cir. 1981), involved
a disclosure request for only the names and addresses of researchers whose proposals had been
denied funding.
6. Initiative 276, 1973 Wash. Laws ch. 1 (codified at Wash. Rev. Code §§ 42.17.010-.955
(1994)).
7. 5 U.S.C. § 552 (1994).
8. For a more detailed discussion on the fanding process and the Freedom of Information Act as
they relate to medical research proposals, see Tammy L. Lewis & Lisa A. Vincler, Storming the
Ivory Tower: The Competing Interests of the Public'sRight to Know and Protectingthe Integrity of
University Research, 20 J.C. & U.L. 417 (1994). Vincler was the attorney of record for U.W. in
PAWS v. U.W.
9. U.W. set forth numerous arguments to support its contention that unfunded medical research
proposals should be exempt from disclosure in their entirety, all of which were rejected by the
majority. U.W. argued for exemption based on several provisions within Washington's Public
Records Act, as well as federal preemption pursuant to patent law, copyright law, the Freedom of
Information Act, and the Bayh-Doyle Act. Progressive Animal Welfare Society v. University of
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while part V examines the practical ramifications associated with it.
Finally, part VI proposes state and federal legislative solutions to
mitigate the impact of this holding.
I.

WASHINGTON STATE AND FEDERAL DISCLOSURE LAWS

Initiative 276, otherwise known as the Public Disclosure Act, ° was
passed by Washington State voters in 1972 by a substantial margin." The
initiative contained four measures, each designed to provide open public
access to governmental activities.1 The initiative reflects the belief that
the sound governance of a free society demands that the public have full
access to information concerning the workings of the government.13 To
promote complete disclosure of information related to the governmental
activities covered in the Public Disclosure Act, the statute further states
that its provisions are to be liberally construed. 4
A.

The PublicRecords Act

In PA WS, the Washington Supreme Court interpreted several
provisions within the Public Records Act," which is the section of the
Public Disclosure Act that specifically relates to the disclosure of public
records. 6 The stated purpose of The Public Records Act (the Act) is to
ensure the sovereignty of the people and the accountability of the
governmental agencies that serve them.17 To further this policy, the
Washington, 125 Wash. 2d 243, 884 P.2d 592 (1994). This Note examines only the argument
involving Wash. Rev. Code § 42.17.330 of Washington's Public Records Act.
10. Initiative 276, 1973 Wash. Laws ch. 1 (codified at Wash. Rev. Code §§ 42.17.010-.955
(1994)).
11. The initiative passed 959,143 to 332,693, an approval rate of 72%. Matthew Edwards, Are
Privacy and Public Disclosure Compatible?: The Privacy Exemption to Washington's Freedom of
Information Act, 62 Wash. L. Rev. 257, 257 n.2 (1987) (citing Washington State Secretary of State,
1972 Abstract of Votes 2).
12. The measures concerned campaign financing; lobbyist reporting; reporting of elected
officials' financial affairs; and public records. Wash. Rev. Code §§ 42.17.010-.955 (1994). The
Public Disclosure Act has since been expanded to include Reports by Public Treasurers [Wash. Rev.
Code § 42.17.245 (1994)] and Political Advertising [Wash. Rev. Code §§ 42.17.505-.540 (1994)].
13. Wash. Rev. Code § 42.17.010(11) (1994).
14. Id.
15. Wash. Rev. Code §§ 42.17.250-.348 (1994).
16. "Public record" is defined as "any writing, containing information relating to the conduct of
government or the performance of any governmental or proprietary function prepared, owned, used,
or retained by any state or local agency regardless of physical form or characteristics." Wash. Rev.
Code § 42.17.020(27).
17. Wash. Rev. Code § 42.17.251 (1994).
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statute specifically states that the Act should be construed liberally and
its exceptions narrowly.18 Courts are instructed to take into account the
Act's policy that free and open examination of public records is in the
public interest, even though such examination may inconvenience or
embarrass public officials or other subjects of the records.1 The Act
requires that state agencies make available for public: inspection and
copying all public records unless a record falls within one of the Act's
enumerated exemptions or is protected by a statute that prohibits
disclosure of the record at issue. 0
In responding to a disclosure request, an agency has five days to either
provide the record, notify the requesting party that it needs additional
time to respond to the request, or to deny the request.2 The agency shall
not distinguish between persons making a disclosure request, nor
generally require the requesting party to disclose the purpose of the
request.2 Under the Act, an agency may attempt to dany a disclosure
request either through an exemption or under Wash. Rev. Code
§ 42.17.330.
The Act's EnumeratedExemptions

1.

The Act contains a provision that creates automatic exemptions for
thirty-three categories of documents.' An agency denying a request
pursuant to an exemption must provide the requesting party with a
written statement identifying the applicable exemption.2' If the requested
record contains both exempt and non-exempt material, the exempt
material may be redacted but the remaining material must be disclosed.s
If the agency denies a disclosure request by claiming that the
document falls within an automatic exemption, the requesting party has
three options. First, the party may accept the agency's decision. Second,
the party may request that the Attorney General review the matter and

18. Id.
19. Wash. Rev. Code § 42.17.340(3) (1994).
20. Wash. Rev. Code § 42.17.260 (1994).

21.
22.
23.
24.

Wash. Rev. Code § 42.17.320 (1994).
Wash. Rev. Code § 42.17.270 (1994).
Wash. Rev. Code § 42.17.310(1)(a)-(gg) (1994).
Wash. Rev. Code §§ 42.17.310(4), .320 (1994).

25. Wash. Rev. Code § 42.17.310(2) (1994). The Act also contain; 10 other automatic
exemptions, Wash. Rev. Code §§ 42.17.312-.31902 (1994), which are not Eubject to the redaction
requirement. Progressive Animal Welfare Society v. University of Washington, 125 Wash. 2d 243,
261 n.8, 884 P.2d 592,602 n.8 (1994).

Public Access to Medical Research
provide a written opinion on whether the record is exempt.26 Finally, the
requesting party may file a motion in superior court to compel the agency
to show cause for refusing the disclosure request.' At the hearing,
judicial review is de novo28 and the agency bears the burden of proving
that the record falls within one of the Act's exemptions or is protected by
another statute prohibiting disclosure of the record. 9 Should the plaintiff
prevail in this action against the agency, the document must be disclosed
subject to court redaction," and the prevailing party is awarded
reasonable attorney's fees incurred in connection with bringing such an
action.3
2.

Section .330

In addition to denying a disclosure request pursuant to one of the
Act's enumerated exemptions, an agency also may attempt to enjoin
disclosure of a specific record pursuant to Wash. Rev. Code § 42.17.330
("section .330") by filing a motion and affidavit in superior court.3 2 The
agency may file such a motion prior to, or in response to, a requesting
party's motion for a show cause hearing under Wash. Rev. Code
§ 42.17.340 3 Section .330 instructs courts to grant the agency's motion

26. Wash. Rev. Code § 42.17.325 (1994). Neither the Act itself nor legislative or case history
shed any light on the impact of such an opinion.
27. Wash. Rev. Code § 42.17.340(1) (1994).
28. Wash. Rev. Code § 42.17.340(3) (1994). Ordinarily, "de novo" review means that the
reviewing court interprets the statutory law and applicable facts independently of the trial court's
interpretation. In the case of a motion under Wash. Rev. Code § 42.17.340, however, de novo review
means that the court will interpret the coverage of the exemption independent of the agency's
interpretation. Hearst Corp. v. Hoppe, 90 Wash. 2d 123, 129-31, 580 P.2d 246,250 (1978).
29. Wash. Rev. Code § 42.17.340(1).
30. See supranote 25 and accompanying text.
31. Wash. Rev. Code § 42.17.340(4) (1994). The statute also gives the court discretionary
authority to award an additional $5 to $100 for each day that the party was denied access to the
record.
32. Wash. Rev. Code § 42.17.330 (1994), "Court protection of public records" provides:
The examination of any specific public record may be enjoined if, upon motion and affidavit by
an agency or its representative or a person who is named in the record or to whom the record
specifically pertains, the superior court for the county in which the movant resides or in which
the record is maintained, finds that such examination would clearly not be in the public interest
and would substantially and irreparably damage any person, or would substantially and
irreparably damage vital governmental functions. An agency has the option of notifying persons
named in the record or to whom a record specifically pertains, that release of a record has been
requested. However, this option does not exist where the agency is required by law to provide
such notice.
33. See supranote 27 and accompanying text.
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to enjoin disclosure of the record only if the agency meets the burden of
proving that disclosure clearly would not be in the pu.blic interest and
would substantially and irreparably damage any person or vital
governmental function.' Exactly when a record raay qualify for
protection under section .330 was a critical issue addressed by the court
in PAWS.
B.

The FederalFreedom of Information Act

The Freedom of Information Act (FOIA), enacted in 1966, was the
congressional response to agency abuse of the public disclosure
provisions of the Administrative Procedure Act. 35 FOIA applies only to
federal agencies; state and local agencies are not included within its
scope.36 In most respects, FOIA and Washington's Public Records Act
are similar. FOIA gives the public access to agency records, puts the
burden of proof for nondisclosure on the agency, and contains nine
specific exemptions from disclosure.3 7 Likewise, it mandates full
disclosure of public records unless they qualify for one of its enumerated
exemptions ' and non-exempt portions of a requested record must be
disclosed as long as they can be reasonably segregated from the exempt
material. 39 FOIA does not, however, contain a counterpart to Wash. Rev.
Code § 42.17.330.40 Therefore, federal courts may not, in ruling on
motions to compel disclosure, exercise discretion Eand balance the
equities of releasing or withholding information sought to be disclosed.4 1
The Washington Supreme Court has noted that the state act closely
parallels FOIA and that judicial interpretations of the latter are therefore
particularly helpful in construing the state act.4 2 The: court also has
indicated that in "many areas" the state act is stricter than its federal

34. See supra note 32.
35. Edwards, supra note 11, at 259 (citing EPA v. Mink, 410 U.S. 73,79 (1973); S. Rep. No. 813,
89th Cong., 1st Sess. 5 (1965)).
36. Ciccone v. Waterfront Comm'n of N.Y. Harbor, 438 F. Supp. 55, 58 (S.D.N.Y. 1977); James
T. O'Reilly, FederalInformation Disclosure § 4.02 (2d ed. 1990).

37. 5 U.S.C. § 552 (1994).
38. Id.
39. 5 U.S.C. § 552(d) (1994).
40. Id.; see also 37A Am Jur 2d, § 74, § 509; O'Reilly, supranote 36, § 9.06.
41. Robles v. EPA, 484 F.2d 843, 848 (1973); Barry v. Washington Post Co., 529 A.2d 319, 321

(1987).
42. Hearst Corp. v. Hoppe, 90 Wash. 2d 123, 128, 580 P.2d 246, 249 (1978).
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counterpart, but the only specific example identified by the court is the
mandatory award of attorney's fees.43
C.

NationalStandardson Disclosureof ResearchProposals

The prevailing practice of federal agencies and academic research
institutions throughout the country is to maintain the confidentiality of
medical research proposals until they are funded. 4 The U.S. Department
of Health and Human Services provides expressly in both its Public
Health Service Grants Policy Statement4 5 and Public Health Service
Grant Application Form46 that application information generally is
available to the public only after the research actually is funded.
As previously noted, FOIA applies to federal agencies, including the
federal funding agencies that receive the grant applications.47 These
agencies rely on two disclosure exemptions within FOLA to deny
disclosure requests of unfunded proposals.4 8 The first claimed exemption
applies to trade secrets and commercial or financial information that is
' The second claimed exemption applies to
"privileged or confidential."49
personnel, medical or "similar files," the disclosure of which would
constitute a "clearly unwarranted invasion of personal privacy."5 °

43. The award of fees is discretionary under FOIA. Animal Welfare Society v. University of
Washington, 114 Wash. 2d 677, 687-88,790 P.2d 604,608-09 (1990).
44. Brief Amicus Curiae of American Council on Education and Association of American
Medical Colleges at 4, Progressive Animal Welfare Society v. University of Washington, (No.
59714-6) [hereinafter ACE Brief]. See also Lewis & Vincler, supranote 8, at 420.
45. Amicus Curiae Brief of the Johns Hopkins University and Washington Association for
Biomedical Research at iv, 8, PAWS v. U. (No. 59714-6) (citing Public Health Service, Grants
Policy Statement, D.H.H.S. Pub. No. (OASH) 90-50,000 (1991)).
The Public Health Service is a division of the Department of Health and Human Services. It
consists of four major components: (1) The Office of the Surgeon General; (2) the National Institutes
of Health; (3) the Bureau of Medical Services, and (4) the Bureau of State Services, and the Agency
for Health Care Policy and Research. 42 U.S.C. § 203 (1994).
46. PHS Grant Application, supranote 1, at 4.
47. See O'Reilly, supranote 36, § 4.02.
48. See Declaration of Joanne Belk, Acting Freedom of Information Officer of the National
Institutes of Health (contained in the appendix of Appellant's Reply Brief to the Brief of Amicus
Curiae American Civil Liberties Union of Washington, PAWSv. U.W. (No. 59714-6)).
49. 5 U.S.C. § 552(b)(4) (1994) (codified at 45 C.F.R. § 5.65 (1994)).
50. 5 U.S.C. § 552(b)(6) (1994) (codified at45 C.F.R. § 5.67 (1994)).
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THE FUNDING PROCESS FOR MEDICAL RESEARCH

There are two primary sources of medical research funding. The
researcher may obtain grants from federal agencies or seek investment
from private companies that hope to commercialize the results of
promising university research."1 The following sections describe these
processes.
A.

FederalFunding

Many federally funded research projects are collaborative efforts
between researchers at different academic institutions. These researchers
combine their individual skills and research to develop proposals that
may receive federal funding. Due to limited resources, the combining of
skills and research often proves invaluable in receiving otherwise
unattainable funds.
Whether conducting research on their own or in conjunction with
another researcher, university researchers who seek federal funding must
first submit their research proposals to the sponsoring university where
the proposals undergo an internal review.52 Review at the university
focuses primarily on the proposal's conformity with university policy
and any financial, administrative, and legal questions that the research
may present.5 3
If the proposed research involves the use of vertebrate animals, the
research also is subject to federal regulation at the university level. In
1966, Congress passed the Animal Welfare Act (AWA),54 which is aimed
at ensuring the humane care and treatment of animals used in medical
research.' The AWA mandates that each research institution utilizing
animals provide an oversight committee responsible for the welfare and
treatment of the animals.56 The Public Health Service (PHS) also requires

51. See Lewis & Vincler, supranote 8, at 421-34.
52. Id. at 421-26.
53. See id. at 422 n.15 (describing internal review process at the University of Washington).
54. 7 U.S.C. §§ 2131-2157 (1988).
55. 7 U.S.C. §§ 2131,2143.
56. 7 U.S.C. § 2143(b) (1988). The committee must be comprised of al least three members,
including one member who is not affiliated with the research facility other than as a committee
member and who is specifically included to represent community interests in the proper care and
treatment of animals. The AWA also mandates semi-annual inspections of the research facility by
the committee, an annual report submitted by the institution to the committee containing assurances
of compliance with the standards set forth in the AWA, identification of any procedures likely to
cause pain to animals, and training of scientists at each of the research favilities on the humane

Public Access to Medical Research
the formation of an animal-care committee as well as institutional
compliance with other requirements aimed at ensuring proper treatment

of animals."
Upon approval at the university level, the university submits the
proposal to one of several federal agencies charged with distributing
federal funds for biomedical research.5" In PAWS, for example, the
proposal was submitted to the National Institutes of Health (NIH). 9 At
the NIH, the submitted proposal is assigned to an appropriate institute
where it undergoes an intensive peer review by university and industry
scientists with expertise in the area of the proposed research.' The
review system at the NIH consists of two levels. The first level evaluates
the scientific merit of the proposal and the second level incorporates
funding priorities and policy considerations. 6 If the proposal is approved
at the first level of review, it is forwarded to the second level where it
undergoes another evaluation and is assigned funding priority based on
the combination of its scientific merit and its relevance to agency
priorities.62 This dual system of review allows the institute to isolate and
focus on the scientific merit of a proposal before policy related
considerations are incorporated into the funding decision.63

treatment of animals and methods of minimizing their pain, and provides for both civil and criminal
sanctions for violations. 7 U.S.C. §§ 2143(b), 2149(b), (d).
57. The PHS Policy on Humane Care and Use of LaboratoryAnimals by Awardee Institutions
requires that the institutions "establish and maintain appropriate policies and procedures to ensure
the humane care and use of live vertebrate animals involved in research activities supported by the
PHS." PHS Grant Application, supra note 1, at 6. The research institution must file an Animal
Welfare Assurance statement with the Office for Protection from Research Risks. As part of its
duties under the PHS assurance procedure, the animal care committee must review and approve the
section of the PHS grant application addressing the use of vertebrate animals. Id. The points to be
addressed under this section include: 1) a description of the proposed use of the animals; 2)
justification of the use of animals and the particular species and number of animals used; 3)
information on their veterinary care; 4) procedures for minimizing their discomfort including the use
ofpain-relieving drugs; and 5) any use of euthanasia. Id. at 22.
58. Lewis & Vincler, supranote 8,at 422.
59. Progressive Animal Welfare Society v. University of Washington, 125 Wash. 2d 243, 248,
884 P.2d 592, 595 (1994). The National Institutes of Health is an agency within the Public Health
Service, supranote 45, and is one of the primary federal research funding agencies.
60. Lewis & Vincler, supra note 8,at 422-23.
61. Id. at n.19 (citing U.S. Department of Health and Human Services, Public Health Service,
National Institutes of Health, Orientation Handbook for Members of Scientific Review Groups 4
(1989)).
62. Id.
63. Cf.Lewis & Vincler, supranote 8, at 422-23.
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Due to limited resources, competition for funding is fierce, and only a
small percentage of grant applications receive funding oia initial review.' 4
A researcher usually receives and incorporates feedback from the
reviewing scientists, often resulting in multiple revisions and
resubmissions of the original proposal." The effectiveness of the peer
review process rests on the confidentiality, objectivity, and impartiality
of the reviewing scientists.' Absent these safeguards, funding decisions
could be based on improper outside influences, such as fear of
harassment. This in turn could threaten the ultimate goal of maximizing
the public benefit through operating a system that bases funding
decisions on the potential and importance of the research.67 Moreover,
any breach of confidentiality could result in intellectual piracy and
plagiarism,68 as well as defeat the patentability of a resulting invention.69
PrivateFunding Through University and Industry Collaboration

B

The second major form of research funding involves collaboration
between universities and private companies that intend to commercialize
any medical or pharmaceutical innovations resulting from the research.7"
There are two basic models of university/industry exchange.71 The first
model involves collaboration in federally funded research.72 The second
involves direct collaboration between industry and universities without
government sponsorship. 73
Both Congress and the Washington Legislature have enacted statutes
that assist in the transfer of technology from public institutions to private

64. Id. at 424.
65. Id. Even after resubmission, the percentage of approved proposal; that actually receive
funding is low. At the NIH in the late 1980s, approximately 27.5% of the grant proposals approved
and submitted by research institutions actuelly were awarded funds. Id. .t 422 (citing National
Institutes of Health, A Plan for Managing the Costs of Biomedical Research 4 (Draft, Jan. 15,
1991)). One medical association submitted the even lower figure of 20%. BriefAmicus Curiae of the
American Psychological Association in Which the Washington State Psychological Association
Joins at 2, Progressive Animal Welfare Society v. University of Washington (No. 59714-6)
[hereinafter APA Brief].
66. See Lewis & Vincler, supranote 8, at 423-26.
67. Id. at 424-26.
68. Id. at 424-25; see also infra part V.B.
69. Id. at 434-40; see also infra part V.A.
70.
71.
72.
73.

Id. at 430-34.
Id. at430.
Id.
Id.
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industry. At the federal level, the Bayh-Doyle Act 4 gives sponsoring
universities intellectual property rights in inventions stemming from
federally funded research. These intellectual property rights are then
transferable to private companies. The goal of the Bayh-Doyle Act is to
create a single, uniform national policy that defines patent rights for the
sponsoring university and the federal government.75 This uniform policy
is intended to benefit U.S. companies that desire to use governmentfunded research, and to encourage the commercial development of any
resulting inventions.76 The Bayh-Doyle Act grants patent rights in
federally funded research to the sponsoring university, but the statute's
"March-in rights" provision allows the federal government to receive
title to and oversee the development of the invention if the university
declines to do so." The Bayh-Doyle Act also contains a
"Confidentiality" section that provides that federal agencies may deny
public access to information related to an invention in which the federal
government owns or may own a right, title, or interest for a reasonable
time in order to file a patent application.78
At the state level, several acts of Washington's legislature have
furthered the interests of the biotechnology industry. For example,
Washington's Uniform Trade Secrets Act79 provides broad means for
courts to protect trade secrets. Additionally, in 1983 the Washington
legislature created the Washington Technology Center, an enterprise that
facilitates collaborative efforts and technology transfer between private
industry and the state's universities.8 0 A third example is the exemption
the legislature included within the Public Records Act for valuable
formulae, designs, drawings, and research data."

74. 35 U.S.C. §§ 200-212 (1988).
75. H.R. Rep. No. 1307, 96th Cong., 2d Sess. 2 (1980), reprinted in 1980 U.S.C.C.A.N. 6460,
6461.
76. Id. at 6461-62.
77. 35 U.S.C. § 203.

78. 35 U.S.C. § 205.
79. Wash. Rev. Code § 19.108 (1994).
80. Wash. Rev. Code § 28B.20.285 (1994); Washington Technology Center, Biennium Report
(1991-1993). The Biennium Report lists 97 industry participants and co-sponsors. While two of the
Center's primary programs are aimed at assisting small and start-up companies located within the
state, some of the larger industry participants include Apple Computers, AT&T, several divisions of
the Boeing Co., Dow Chemical Corp., IBM Corp., Johnson & Johnson, and 3M Corp.
81. Wash. Rev. Code § 42.17.310(I)(h). The trial court in PAWS v. U.W. redacted certain material
from the proposal pursuant to this exemption. This exemption, however, may provide insufficient
protection for some valuable material in the proposal. See infra part V.
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III. PAWS V U.W.
A.

ProceduralAspects and Facts

Following internal review and approval by the U.W., a proposal by
83
Dr. Gene Sackett82 and Dr. Linda Cork was submitted to the NIH8
PAWS submitted its disclosure request to the U.W., 85 presumably
because federal agencies routinely deny disclosure requests for unfunded
medical research proposals under FOIA.86 The request was denied by
U.W.'s Public Records Officer and a subsequent request was denied by
U.W. President William Gerberding" PAWS then filed suit pursuant to
Wash. Rev. Code § 42.17.340 of Washington's Public Records Act to
compel disclosure of the proposal. 8
Both parties moved for summary judgment. U.W. argued that as a
matter of law the proposal was exempt in its entirety." PAWS

82. Dr. Sackett is a University of Washington professor of psychology ani Associate Director for
Behavioral Research at the Child Development and Mental Retardation Ctnter, and research staff
member of the Regional Primate Research Center located at the U.W.
83. Dr. Cork is a Johns Hopkins University researcher and was the preliminary investigator in the
research.
The proposal was based on previous research conducted by Dr. Cork. As of the time of the case,
Dr. Cork had not published any results of the research and had revealed the research only for the
purpose of supporting the funding application. Amicus Curiae Brief of The Johns Hopkins
University and Washington Association for Biomedical Research at 10, Progressive Animal Welfare
Society v. University of Washington (No. 59714-6).
The grant proposal was entitled "Effects of Socialization on Forebrain Development" The
research involved studying the behavioral development of socially deprived, rhesus monkeys in the
hope of better understanding and treating self-injurious behavior displayed by certain mentally ill
people. Dr. Sackett and Dr. Cork hypothesized that such disorders were caused by abnormal
neurobiology and sought to isolate the particular chemical processes responsible for bringing about
such abnormalities. To accomplish this goal, the researchers proposed to isolate some monkeys for
one year, then to contrast their behavior with a control group of monkeys raised in a social
environment. The monkeys would then be euthanized in order to study the neurochemistry of their
brains. Brief of Appellant at 7-8, PA WSv. U.W. (No. 59714-6).
After PAWS initiated its lawsuit, NIH ultimately denied federal funding. Lewis & Vincler, supra
note 8, at 420 n.9.
84. Progressive Animal Welfare Society v. University of Washington, 125 Wash. 2d 243, 248,
884 P.2d 592, 595 (1994).
85. Id. at 247, 884 P.2d at 595.
86. See supranotes 48-50 and accompanying text.
87. PAWS, 125 Wash. 2d at 250, 884 P.2d at 596.
88. Id.
89. Id. U.W. argued that the unfunded proposal in its entirety qualified for protection under
several exemptions: Wash. Rev. Code § 42.17.310(l)(b), (h), (i). Id. at 254-S 6, 884 P.2d at 598-600.
For reasons beyond the scope of this Note, the court rejected all of these arguments.
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maintained that it was entitled to disclosure of the unfunded proposal
with the exception of certain material that might reveal confidential or
sensitive formulae, designs, drawing, research data, or trade secrets.9"
After an in camera review, the court excised such material as well as
certain budgetary information all of which, in the court's view, "an
educated reader could use to reveal research hypotheses or data, valuable
formulae and the like."91 The trial court then granted PAWS's motion for
summary judgment and ordered disclosure of the remaining material.92
B.

The Holding

The majority rejected U.W.'s argument that the court could and
should enjoin disclosure of the proposal in its entirety pursuant to section
.330.9' The majority limited itself to two options in interpreting section
.330: either the statute was a "general exemption," or it was an injunctive
remedy that could be invoked only if the specific record first qualified
for one of the enumerated exemptions within the Act.94 The majority
chose the latter interpretation and held that, because the proposal in its
entirety did not fall within one of the Act's exemptions, the court was
precluded from even considering the proposal for enjoinment under
section .330.

U.W. also argued that unfunded medical research proposals were exempt in their entirety on the
basis of federal preemption. U.W. asserted that states were preempted from mandating disclosure
due to conflicts with four areas of federal occupation: (1) FOIA; (2) federal patent law; (3) federal
copyright law, and (4) The Bayh-Doyle Act. The majority rejected these arguments for several
reasons. First, the majority noted that FOIA did not expressly preempt similar state acts, nor did it
pervasively or comprehensively occupy the field of public disclosure so as to preempt state action in
the area. Second, the majority asserted that the redaction of the material by the trial court adequately
protected U.W.'s patent rights and copyrights. Finally, the court asserted that because FOIA and the
Bayh-Doyle Act applied only to federal and not state agencies, neither of these acts preempted state
regulation of public disclosure. PAWS, 125 Wash. 2d at 265-67, 884 P.2d at 604-06.
90. Id. at 250, 884 P.2d at 596. Specifically, PAWS requested, inter alia, disclosure of sections of
the proposal addressing "Specific Aims," "Background and Significance," "Progress
Report/Preliminary Studies," "Experimental Design and Methods," "Literature Cited,"
"Consultant/Collaborators,' and "Consortium/Contractual Arrangements." ACE Brief, supra note

44, at2.
91. PAWS, 125 Wash. 2d at 250, 884 P.2d at 596.

92. Id. The trial court also granted attorney's fees to PAWS pursuant to Wash. Rev. Code
§ 42.17.340(4), but declined to award the discretionary penalties authorized by the same section. Id.
93. Id. at 257-61, 884 P.2d at 600-02.

94. Id.
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IV. ANALYSIS OF PA WS V. U.W.
A.

The PAWS Holding Conflicts with a Sound Washington Precedent

The majority's interpretation of section .330 in PAWScontradicted the
Washington Supreme Court's unanimous interpretation of the same
statute in Dawson v. Daly.9' Dawson involved a disclosure request by
Daly, a former law enforcement officer who appeared frequently as a
defense expert witness in child sex-abuse prosecutions in Snohomish
County, Washington. Daly requested numerous documents, including
files that Snohomish County prosecutors had developed for use in crossexamination. The court in Dawson discussed whether the requested
documents fell within several of the Act's enumerated exemptions. The
court also interpreted section .330 as providing a se,.arate means by
which an agency may attempt to withhold disclosure of a specific
document. In so doing, the court stated the following:
We hold that RCW 42.17.330 does create an independent basis
upon which a court may find that disclosure is not required if the
court, upon a request for an injunction under RCW 42.17.330, finds
(1) that disclosure is not in the public interest and (2) that
disclosure would cause substantial and irreparable damage to a
person or a vital governmental function.9 6
The Dawson interpretation of section .330 recognized the statute not
as an exemption, but as a separate and discretionary basis upon which a
court may find that disclosure of a specific record is not required." As
noted by the dissent in PAWS, "[a]n exemption is absol[ute; section .330

95. Dawson v. Daly, 120 Wash. 2d 782, 845 P.2d 995 (1993). The decision inDawson was 9 to 0.
Interestingly, two of these nine justices participated in the majority opinion of PAWS, and another
two participated in the concurrence. Only three out of the nine justices who participated in the
Dawson decision remained consistent and participated in the PAWS dissent
96. Id. at 794, 845 P.2d at 1002. The court then differentiated between the two distinct avenues by
which an agency may attempt to withhold disclosure of a record. The court fi-st described the avenue
that involved an agency invoking an enumerated exemption, then differentiated this from the avenue
involving section .330. While the former allowed an agency to withhold a record on its own
initiative, the court explained, the latter required court intervention and a determination of whether
the requirements contained in section .330 were met. The court concluded its discussion of section
.330 by holding that if, on remand, the trial court found that the requirements of section .330 were
met, an injunction barring access should be entered. Id.
97. At least one other state court has interpreted a provision of its public disclosure act in a
manner consistent with Dawson. In Civil Service Comm'n v. Pinder, 812 P.2 d 645 (Colo. 1991), the
Colorado Supreme Court held that Section 24-72-204(6) of Colorado's Opea Records Act provided
a discretionary basis for a court to deny public access to otherwise accessible records if the court
finds that disclosure would cause "substantial injury to the public interest." Id. at 648.

Public Access to Medical Research
is a grant of individualized discretionary authority.""8 Furthermore, while
the enumerated exemptions apply to general categories of documents,
section .330 relates to specific documents on a case-by-case basis that an
agency seeks to withhold from disclosure.
Had the legislature intended to impose upon the agencies the burden
of first establishing that the record qualified for an exemption before the
court may even consider issuing a section .330 injunction, it simply
could have done so by inserting language in section .330 to that effect,
rather than inserting the carefully crafted requirements contained in the
statute. 9 According to the majority in PAWS, the requested document
must qualify for an exemption whether the agency chooses to deny a
disclosure request by invoking an automatic exemption or by filing a
section .330 motion. However, under the majority's interpretation, only
if the agency chooses to file a section .330 motion will the agency also
bear the burden of proving that disclosure of the document will clearly
not be in the public interest and will substantially and irreparably damage
any person or vital governmental function. This differing treatment,
based solely on which method the agency chooses to utilize in denying a
disclosure request, is difficult to justify.
The majority in PAWS downplayed the significance of Dawson and
discussed its concern with adopting the Dawson interpretation of section
.330. The majority began by characterizing the Dawson court's
interpretation of section .330 as dicta rather than a holding.le e The
majority then set forth its concern that if the court adopted the Dawson
interpretation of section .330 and enjoined disclosure of the unfunded
proposal pursuant to that provision, the court would be repeating its error
in In re Rosier.'0' In Rosier, the court interpreted Wash. Rev. Code
§ 42.17.260 in a manner that allowed the court to create a general
disclosure exemption for personal privacy."0 2 The Washington

98. PAWS, 125 Wash. 2d at 275, 884 P.2d at 610 (Brachtenbach, J., dissenting).
99. See supra note 32.
100 PAWS, 125 Wash. 2d at 261 n.7, 884 P.2d at 602 n.7. Not only does the court's use of the
actual words "We hold" indicate that the decision regarding the proper interpretation of section .330
was a holding, a subsequent Washington Court of Appeals opinion also interpreted it as such. In
Brown v. Seattle Public Schools, 71 Wash. App. 613, 860 P.2d 1059 (1993), the court referred to
Dawson extensively and at one point states, "In addition, in Dawson, the Supreme Court held that
RCW 42.17.330 creates 'an independent basis upon which a court may find that disclosure is not
required."' 71 Wash. App. at 618, 860 P.2d at 1062 (quoting Dawson, 120 Wash. 2d at 793-94, 845
P.2d at 1002).
101. In re Rosier, 105 Wash. 2d 606,717 P.2d 1353 (1986).
102. Id. at 609, 717 P.2d at 1356. Wash. Rev. Code § 42.17.260 is a procedural section that
instructs the agencies of their general disclosure obligations and the means by which they may deny
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Legislature specifically overturned the Rosier holding by amending that
statute and proclaimed that the intent of the amendment was to make
clear that "[a]gencies having public records should rely upon statutory
exemptions or prohibitions for refusal to provide public :records."'' 3
The majority's concern in PAWS was predicated on a
mischaracterization of the Dawson holding and a misunderstanding as to
what the legislature's response to Rosier meant to prohibit. The Dawson
court interpreted section .330 as a general exemption only in the sense
that a court may exempt specific records that do not otherwise qualify for
protection under one of the Act's enumerated exemptions based on the
unique characteristics of the specific record and the facts involved in the
case. In contrast, the legislature overturned Rosier because the court
created a general disclosure exemption, similar to the automatic
exemptions found in Wash. Rev. Code § 42.17.310(l)," 4 based on a
certain type of interest - privacy. The statute at issue in Rosier, Wash.
Rev. Code § 42.17.260, and the legislature's proclamation as to the intent
of its amendment refer only to the avenue of non-disclosure involving
automatic exemptions for certain types of interests or for certain
categories of documents, not section .330, which requires court
intervention and discretion in enjoining disclosure of specific records.
The Dawson interpretation of section .330, therefore, would allow a
court to rule that a particular record may be withheld by an agency
without creating a general exemption for that type of document, thus
avoiding the error of Rosier.
The majority's fear of legislative reprisal also overlooked the fact that
the legislature declined to amend section .330 following the court's
holding in Dawson in both the 1993 and 1994 sessions. Given the
legislature's willingness to respond to the court's interpretation of the
Public Records Act, as seen by the response to Rosier, its inaction
suggests approval.
B.

The Majority's Interpretationof Section .330 Renders It
Superfluous

One canon of statutory construction dictates that courts should
interpret a statute in a manner that gives meaning to all portions of the
statute, not in a manner that renders any portion meaningless,
a disclosure request without seeking court intervention, i.e., by invoking one of the automatic
exemptions.
103. 1987 Wash. Laws, ch. 403, § 1, pp. 1546-47.
104. See supranote 23 and accompanying text.
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superfluous, or questionable. 5 The second troubling aspect of the PAWS
majority's interpretation of section .330 is that it rendered the provision
superfluous. Section .330 became essentially meaningless once the
majority held that the provision may be invoked only if the document
first qualifies for protection under one of the enumerated exemptions of
the Act. If a document falls within a class of documents that is
automatically exempt, there remains little reason for an agency to seek
court protection pursuant to section .33Q*106
Ironically, the majority in PAWS argued that the Dawson
interpretation of section .330 rendered the Act's enumerated exemptions
superfluous. 7 This assertion was misguided for several reasons. First,
the enumerated exemptions address an avenue of non-disclosure that is
entirely different from the avenue addressed by section .330. While the
former allows for automatic withholding of the requested record, the
latter requires court intervention.
Second, the majority overlooked the heavy burden that the agency
must meet in order to prevail in a section .330 action. The agency must
effectively prove three elements: (1) a clear lack of public interest in
disclosure; (2) substantial and irreparable harm to a governmental
function; and (3) the vital nature of the governmental function." 8
Presumably, agencies will try to avoid this burden and do so when
invoking an automatic exemption. According to the Dawson holding, an
otherwise non-exempt record would face scrutiny under this burden, thus
addressing the concern of the majority in PAWS that courts could
haphazardly enjoin disclosure of an otherwise non-exempt document.0 9
Finally, the majority failed to consider the extensive time and
litigation costs that agencies would expend were they always to resort to
court intervention pursuant to section .330 rather than opt for protection
of the document under an automatic exemption. Though the statutory
scheme of the Act would allow for this general approach to denying

105. Lutheran Day Care v. Snohomish County, 119 Wash. 2d 91, 829 P.2d 746 (1992).
106. One unlikely explanation is that an agency might seek court protection pursuant to section
.330, even if it believes that an exemption truly applies, in order to hedge against the possibility of
being assessed attorney's fees should the requesting party attempt to compel disclosure pursuant to
Wash. Rev. Code § 42.17.340 and prevail.
107. Progressive Animal Welfare Society v. University of Washington, 125 Wash. 2d 243, 260,
884 P.2d 592, 601-02 (1994).
108. See supranote 32.
109. The PAWS majority's exact words were "simply declare records covered by personal privacy
or vital governmental interests without ever having to invoke or construe the exemptions of RCW
42.17.310." PAWS, 125 Wash. 2d at 260, 884 P.2d at 602.
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requests for automatically exempt records, such an approach would
undermine the intent of the exemptions and is logistically unimaginable.
V.

PRACTICAL IMPLICATIONS OF THE PAWS HOLDING

Though the majority did rule that a trial court may redact certain parts
of the proposal pursuant to the "valuable formulae" exemption,1
redaction by a trial judge may provide insufficient p:rotection for the
researcher and the proposal. The primary conce:ms of medical
researchers, the sponsoring universities, the federal government, and
private industry are the loss of patent rights and the intellectual piracy
that may result from unwitting and premature disclosure of sensitive
information. The potential for intellectual piracy and th1e loss of patent
rights in turn creates several serious threats to the friture of research
conducted in Washington and jeopardizes the development of important
medical and pharmaceutical innovations.
A.

Disclosureof PreliminaryProposalsMay Result in the Loss of
PatentRights

The Patent Act requires patentable inventions to be useful, novel, and
1 To be non-obvious, an invention cannot be considered
non-obvious."
prior art to a person with ordinary skill in the relevant art112 at the time
the invention was made."' Under the novelty requirement, no patents
will issue if the invention is described in a printed publication and the
inventor fails to file a patent application within one year." 4 Most foreign
countries provide for a shorter grace period." 5 Germany, for example,
provides for only a six-month grace period and protects only a disclosure
by the inventor, or his or her legal predecessor, at an officially
recognized exhibition." 6 Thus, almost any publication of an invention in
the United States would render the invention unpatentable by the
researcher in Germany.'

110. Wash. Rev. Code § 42.17.310(1)(h).
111. 35 U.S.C. §§ 101-103 (1988).
112. In this context, the word "art" effectively means technical field.
113. 35U.S.C. § 103.
114. 35U.S.C.§ 102.
115. Charles R.B. Macedo, First-to-File:Is the American Adoption of the InternationalStandard
in PatentLaw Worth the Price?,18 AIPLA Q.J. 193,204 (1990).
116. Id.
117. Id.
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In the early, unfunded stages of a research proposal, it is nearly
impossible for the researchers to identify all the information that may be
important to a future patent application and which information must be
protected to ensure that the confidentiality of the research is not
compromised. A superior court trial judge is even less able to make these
vital determinations. Not only is the field of medical research complex
and highly specialized, most superior court trial judges have little to no
experience in trying patent cases because such cases ordinarily are
handled by the federal courts and appeals are handled by a special branch
of the federal courts. The trial judge will be faced with foreign issues and
information and will need to apply the complex patent standard that
requires the judge to redact any information that would render the
invention obvious to a person with skill in the field of biomedical
research, not only the information that would allow an "educated reader"
to deduce sensitive information. Ultimately, despite the best efforts of
judges to excise any potentially patentable and sensitive material, judges
may unwittingly disclose too much.
B.

Disclosureof PreliminaryResearchProposalsMay Facilitate
IntellectualPiracy

A second underlying concern of premature disclosure is the
impending threat of intellectual piracy that may result from disclosure of
trade secrets and other sensitive information. Access to the specific
formulae, data, or research hypothesis of a proposal is not always
necessary for other scientists with experience in the pertinent area to
deduce the procedures necessary to carry out the research. Often, crucial
information can be deduced from seemingly innocuous information, such
as a description of the research aims or bibliographies of published
related research." 8 Intellectual piracy is devastating to researchers who
may spend years preparing a single grant proposal, only to see their
efforts stolen by aggressive competitors who may then reap the rewards
of the resulting invention.
C.

Industry Funding of University-SponsoredResearch in Washington
May Decline

Private biotechnology companies that invest in research development
collaborations with Washington's public institutions do so only if they
are reasonably certain that patent rights are protected, licensing
118. ACE Brief, supranote 44, at 8-9.
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agreements are exclusive, and new technology cannot be utilized by
competitors. Without such assurance, companies cannot afford to invest
the necessary money for commercial development, thus further
jeopardizing already costly and risky ventures."' A retreat of industry

funding may prevent development of many valuable and possibly lifesaving medical and pharmaceutical inventions. 2 '
A related concern is the possible withdrawal of private biotechnology
companies from Washington. Washington is home to at substantial and
rapidly growing biotechnology community,' due in great part to the
desire of such companies to maintain close proximity to the valuable
technology and skilled researchers housed at Washington's research
institutions." 2 Without secure patent and trade-secret rights, these private

119. On average, it takes 12 years to bring a prescription drug to market in the United States. The
odds of getting a new compound to the market are I in 10,000. The dollar investment for one
prescription medicine averages $231 million. Of the drugs that reach the marketplace, only 3 out of
10 even recoup the average cost of research and development. P. Roy Vagelos, Are Prescription
DrugPricesHigh?, 252 Science 1080-82 (May 24, 1991).
120. One example, cited by U.W. in its trial brief, involved the stalled comraercial development of
research conducted by two U.W. researchers. Their research led to the development of an antibody
with multiple potential benefits, including the treatment of victims of hemcrrhagic shock (trauma
due to blood loss). Despite a showing of life-saving potential, the patent rights were compromised by
premature publication of information regarding the antibody. As stated by one of the researchers:
The end result is even though the antibody has great potential to prevent lifethreatening organ
failure in trauma victims, and is licensed to a major pharmaceutical company, no drug company
has been willing to invest the time and money to market the product because the patent and trade
secret protection for the antibody was compromised.
Declarations of Dr. Charles L. Rice (Vice Chairman of the Department of Surgery at the University
of Washington School of Medicine, Surgeon-in-Chief at Harborview Medical Center, Research
Affiliate of the Regional Primate Research Center at the University of Washington) and Dr. John
Harlan (Professor and Head of the Division of Hematology at the University of Washington School
of Medicine) (Contained in Brief of Appellant at 29, Progressive Aninml Welfare Society v.
University of Washington (No. 59714-6).
121. The Seattle area is one of the six main biotechnology centers in the United States.
Washington State Biotechnology TargetedSector Advisory CommitteeReport to the Legislature at 34. (Jan. 1992) [hereinafter Biotech. Report]. Washington's biotechnology industry currently
generates more than $500 million annually and employs nearly 5,000 people in more than 60
companies and nonprofit organizations. Washington Industry Profile: Biotechnology at 2 (pamphlet
published by Washington CEO Magazine, on file with Washington Law Revie,).
The U.W. derives substantial licen.-" ig revenue from private companies. i fiscal year 1994, the
U.W. received $7A5 million from licensing its intellectual property, bringing its cumulative profit
since 1984 to $26.83 million. Seth Adkins, Scientists Turn Technological Ideas Into Revenue
Sources, The Daily (University of Washington student newspaper), Feb. 27, 1995, at 2.
122. The institutions include the University of Washington, Washington State University, Eastern
Washington University, and the Fred Hutchinson Cancer Research Center. Biotech. Report, supra
note 121, at4.
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companies may not only withhold investment but may leave the state
altogether.
D.

CollaborationBetween U.W. andResearchers Outside of
Washington May Decline

By deviating from the nationwide policy of withholding disclosure of
unfunded research proposals, Washington severely impedes the
incentives for researchers at institutions outside of Washington to
collaborate with Washington-affiliated researchers. Because their
sensitive, preliminary research is threatened only in Washington,
potential collaborators now have reason to look toward institutions
located elsewhere. This jeopardizes future receipt of the vast funds
granted to U.W. researchers involved in inter-university collaborative
research. Additionally, Washington's liberal disclosure law may
compromise the reputation of U.W. as a top research institution that
actively promotes and protects the rights of its researchers.
E.

U.W. 's Ability to Attract and Retain Quality ResearchersMay Be
Hampered

Washington's research institutions now may find it more difficult to
attract and retain strong faculty. While technically it is the sponsoring
university that suffers from the loss of patent rights, the researchers also
suffer from premature disclosure of sensitive information. In an
environment where the competition for funding and standing in the
medical research community is fierce, intellectual piracy has devastating
effects on the livelihood of researchers. The results of years of intense
efforts may be lost. Intellectual piracy deprives the researcher of credit
for the invention and may prevent the publication of the research
information because many journals will not publish information that
previously has been published elsewhere."n These consequences can
prove devastating to the researchers whose tenure, promotions, and
standing in the academic community depend largely on any inventions
and publication in scholarly journals. 24 In order to avoid these threats,
researchers may prefer to work at institutions that are able to maintain
the confidentiality of preliminary, unfunded research concepts.

123. Id.
124. APA Brief, supranote 65, at 12.

949

Washington Law Review
F.

Vol. 70:929, 1995

The Effectiveness of the PeerReview ProcessMay. e Adversely
Affected

Due to the nature of the peer review process, which -depends on open
and candid exchange, full disclosure of research infbrmation to the
funding agency is crucial. Researchers who fear premature dissemination
of their research likely will become reluctant to fully disclose their ideas
and preliminary results. The content of disclosure also may be affected
by fear of reprisal from groups having access to unfunded proposals who
oppose and harass researchers engaged in certain types of research."z
Any reluctance to disclose less than all material to peers will compromise
the effectiveness of the review.
Groups in possession of unfunded proposals may also affect the
objectivity and impartiality of the peer reviewers by subjecting them to
political pressures and possibly even harassment, thereby threatening the
effectiveness of a process that relies on a delicate balance of objective,
merit-based review and policy-oriented considerations.
VI. SUGGESTED COURSES OF ACTION TO MINIMIZE THE
IMPACT OF PAWS
To minimize the adverse effects of the PAWS holding in Washington
and nationwide, several corrective measures could be undertaken at the
judicial and legislative levels. First, the Washington Legislature should
amend Wash. Rev. Code § 42.17.310 to include an express exemption
for unfunded medical research proposals. Such an amendment will prove
125. In PAWS, the court discussed a letter written from Dr. Sackett to a U.W. official. In the letter,
Dr. Sackett described the harassment he had been subjected to as an animal researcher as well as the
fear of attack harbored by animal researchers. Progressive Animal Welfare Society v. University of
Washington, 125 Wash. 2d 243, 268 n.13, 884 P.2d 592, 606 n.13 (1994).
Lewis & Vincler, supra note 8, at 453 nn.200-01, lists many such examples including: Standoff
Broken in Animal Rights Protest in Md., Wash. Post, Aug. 1991, at 03 (discussing animal rights
protesters picketing researcher's home over four month period); Animal Activists Target Home of
Researcher,U.S. Medicine, Sept. 1991; ProtestersStalk Researcher Over CatExperiments, Wash.
Post, June 23, 1991, at Cl; Constance Holden, Animal Rightists Trash MSU Lab, Science, Mar. 13,
1992, at 1349 (discussing fire set by the Animal Liberation Front (ALFI) to a Michigan State
University laboratory that caused approximately $75,000 worth of damage); Eric Sorenson, Activists
Vandalize WSULabs, Release Research Animals, Spokesman-Review (Spokame), Aug. 14, 1991, at
Al (discussing ALF raid on Washington State University lab that resulted in damage to lab
equipment and the release of minks and coyotes); Dave Birkland, Animal Rights Group Claims It
StartedBig Edmonds Fire,Seattle Times/Seattle Post Intelligencer, June 16, 1991 at Al (discussing
ALF's claim of responsibility for animal food co-op warehouse arson and their expressed desire to
cause "maximum economic damage"); Jeff Wright, Radicals Say They Set Fire, Eugene Register
Guard, June 11, 1991 (discussing fire set by ALF to an Oregon State University research barn and
destruction of research records and vandalism of research equipment).
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the swiftest and most effective means of formally addressing this
problem in Washington state. The public does have an interest in
monitoring the expenditure of public funds for research. However, in
light of the safeguards already established to represent public interests in
research, and given the risks associated with premature disclosure of
research information, the national policy of allowing public access to
proposals only after funding strikes the correct balance between the
public's right to know and the researchers' need for confidentiality in the
proposal process.
Regardless of any response by the Washington Legislature, Congress
should expressly preempt state law mandating disclosure of unfunded
medical research proposals. Because the federal government has rights in
any federally funded research pursuant to the "March-in rights"
provision of the Bayh-Doyle Act,'26 it has a significant interest in
protecting the patentability of the inventions. Washington's current
position conflicts with the intent of the Bayh-Doyle Act to support and
improve U.S. technological innovation and industry investment. A
practice of protecting unfunded proposals at the federal level by invoking
the pertinent FOIA exemptions12 7 will prove futile if the sensitive
information is released at the state level. Not only would congressional
action settle this problem in Washington, it also would prevent other
states from deviating from the current national standard, thus preventing
the spread of a counterproductive policy.
In the meantime, courts in states with public records acts similar to
Washington's should decline to follow Washington's example. Because
PAWS is a case of national first impression, and U.W. is a leading
recipient of federal research grants, other state courts may look to
Washington's current policy on disclosure of unfunded research
proposals as persuasive authority in deciding similar cases. Any state
interested in avoiding the risks associated with forced disclosure of
unfunded medical research proposals should refuse to follow
Washington's example and instead continue to follow the national
standard of respecting the confidentiality of unfunded medical research
proposals.
VI. CONCLUSION
Washington's Public Records Act serves a valuable and necessary
function. It helps ensure that the government remains of the people and
126. See supra note 77 and accompanying text.
127. See supranotes 48-50 and accompanying text.
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for the people. It was designed to serve Washington's citizens and to
safeguard and further their interests. However, the PAWFPS holding placed
too little weight on a nationwide policy of maintaining the confidentiality
of unfunded medical research proposals. The result is the adoption of a
policy that is detrimental to the interests of the citizens of Washington
and to progress in biomedical research.
The most difficult aspect of drafting public disclosure laws is knowing
where to draw the line between the public's right to oversee the
government and the need for an effective government that is free from
undue interference. Hopefully, the Washington legislature and Congress
will realize that this line has been crossed and will act quickly to
properly reset it.

